Improving pediatric asthma management with an advanced electronic stethoscope
Telemedicine System and Intelligent Monitoring System Construction of Pediatric Asthma Based on the Electronic Stethoscope
NA · Shanghai Children's Medical Center · NCT05659225
This study is testing a new smart stethoscope to see if it can help doctors better monitor and manage asthma in children.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 208 (estimated) |
| Ages | 3 Years to 6 Years |
| Sex | All |
| Sponsor | Shanghai Children's Medical Center (other) |
| Drugs / interventions | prednisone |
| Locations | 1 site (Shanghai, Shanghai) |
| Trial ID | NCT05659225 on ClinicalTrials.gov |
What this trial studies
This project aims to enhance the existing electronic stethoscope to improve the quality of breath sound data acquisition and processing for children with asthma. By integrating artificial intelligence and advanced signal processing, the study seeks to simplify data transfer and reduce the operational burden on caregivers. Participants will be randomly assigned to either a control group or a group using the modified electronic stethoscope, allowing for remote monitoring and management of asthma symptoms. The ultimate goal is to create an intelligent monitoring system that facilitates better asthma management for pediatric patients.
Who should consider this trial
Good fit: Ideal candidates are children aged 3 to 6 years diagnosed with asthma who are receiving long-term maintenance therapy.
Not a fit: Patients experiencing acute asthma exacerbations or with other chronic lung diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve asthma control and management for children, leading to better health outcomes.
How similar studies have performed: While the integration of telemedicine and intelligent monitoring systems is gaining traction, this specific approach using an enhanced electronic stethoscope is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" in the respiratory clinic of Shanghai Children's Medical Center from January 2023 to January 2025 2. Out-patient, female or male, 3 years old≤ age \< 6 years old 3. long-term maintenance therapy with inhaled glucocorticoids or concomitant leukotriene receptor antagonists 4. Equipped with a household atomizer or spacer, it can afford the inhalation therapy of short-acting β2 receptor agonists (SABA) at home 5. The subjects or subjects' caregiver must have a smart phone with Android or Harmony system at their disposal 6. The guardian agrees to participate in the study and signs the informed consent form Exclusion Criteria: 1. Acute exacerbation of asthma 30 days before enrollment (receive short-term prednisone treatment, emergency department visit or hospitalization due to acute asthma attacks) 2. Other chronic lung diseases, cardiovascular diseases, blood system diseases, immunodeficiency diseases, neurological diseases, genetic or chromosomal abnormalities and other underlying diseases 3. Patients or their caregivers can't complete the collection of breath sound
Where this trial is running
Shanghai, Shanghai
- Shanghai Children's Medical Center — Shanghai, Shanghai, China (RECRUITING)
Study contacts
- Principal investigator: Yong Yin, PhD — Shanghai Children's Medical Center
- Study coordinator: Yong Yin, PhD
- Email: yinyong9999@163.com
- Phone: 8618930830705
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Asthma, Pediatric, Asthma Control, Electronic Stethoscope